- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/68 - Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Patent holdings for IPC class C07D 277/68
Total number of patents in this class: 191
10-year publication summary
17
|
8
|
8
|
14
|
12
|
10
|
11
|
10
|
6
|
8
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Promega Corporation | 572 |
12 |
AstraZeneca AB | 2917 |
10 |
Agios Pharmaceuticals, Inc | 216 |
6 |
AstraZeneca UK Limited | 650 |
4 |
Sumitomo Chemical Company, Limited | 9040 |
4 |
University of Mississippi | 156 |
4 |
Vectus Biosystems Limited | 35 |
4 |
Novartis AG | 10867 |
3 |
Janssen Pharmaceutica N.V. | 3399 |
3 |
Syngenta Participations AG | 1907 |
3 |
Bayer AG | 3327 |
3 |
Bayer Cropscience AG | 2042 |
3 |
Korea Institute of Science and Technology | 2115 |
3 |
Diaxonhit | 6 |
3 |
Naegis Pharmaceuticals Inc. | 3 |
3 |
Genentech, Inc. | 3975 |
2 |
Merck Patent GmbH | 5829 |
2 |
FUJIFILM Corporation | 29305 |
2 |
Takeda Pharmaceutical Company Limited | 2711 |
2 |
Astellas Pharma Inc. | 1087 |
2 |
Other owners | 113 |